Comparison NewAmsterdam Pharma (NAMS) with Competitors
NewAmsterdam Pharma (NAMS) industry is Biotechnology.
Operating Margin
NAMS-1922.00%
Industry-2055.25%
Upside+133.25%
Free Cash Flow Yield
NAMS-3.80%
Industry-1.75%
Upside-2.06%
P/E
NAMS-17.19
Industry-20.52
Upside+333.11%
P/S
NAMS165.68
Industry10.01
Upside+1554.56%
P/B
NAMS5.85
Industry5.15
Upside+13.66%